Viewing Study NCT00421369


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-31 @ 3:21 AM
Study NCT ID: NCT00421369
Status: COMPLETED
Last Update Posted: 2013-03-22
First Post: 2007-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.
Sponsor: Hadassah Medical Organization
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Major Depressive Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Major depressive disorder View
None Antidepressants View
None Triiodothyronine (T3) View
None Thyroid Function View
None Augmentation View
None Thyroid pathway genes View